FounderNest™

Start exploring your own markets for free

🚀 Try for Free

/Remote Monitoring for Biomarkers

Invite

Pending to review

Not sure yet

Interested

Not interested

Download list

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
dreaMS	MyHealios effectively employs remote monitoring technologies and focuses on the identification and validation of digital biomarkers to enhance clinical trials and patient care.	Combining consumer devices' sensor data with AI, Dreams generates Digital Biomarkers to improve MS diagnosis and treatment monitoring. dreaMS is a Software as Medical Device (CE-Mark) designed to assess neurological functions using novel Digital Biomarkers focused in the following domains: Movement, Balance, Dexterity and Vision dreaMS is the product of a collaboration between Healios and RC2NB, a neuroscience research foundation connected to Universitätsspital Basel led by Professor L Kappos.	Digital Biomarkers Development	Light Search	Flemington (United States)	2011	11 - 50	$4.20M	Seed, August 30, 2022	Oct 14, 2024
Predible Health	nference develops advanced technologies that leverage real-world data for remote monitoring, optimizing clinical trials, and identifying digital biomarkers.		Digital Biomarkers Development	Light Search	Bengaluru (India)				Seed, March 1, 2018	Oct 14, 2024
Circadic	Circadic effectively utilizes remote monitoring technologies to advance clinical trials and identify digital biomarkers, contributing to the development of digital health solutions.	The company specializes in piloting digital biomarker discovery studies and aims to improve lives by using unobtrusive means. They partner with pharmaceutical and research organizations to reimagine the future of digital medicine.	Digital Biomarkers Development	Light Search	Oslo kommune (Norway)		1 - 10		NA	Oct 14, 2024
Current Health	Current Health effectively adopts remote monitoring technologies, advances clinical trials, and identifies digital biomarkers, making it a strong fit for the specified requirements.	Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.	Digital Biomarkers Development	Light Search	Boston (United States)	2015	51 - 200	$492.72M	Acquired by Best Buy, October 2021	Oct 14, 2024
Indivi	Indivi effectively utilizes remote monitoring technologies to identify and validate digital biomarkers, advancing clinical trials in neuroscience.	Indivi is a Medical Device Software Manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies. With novel, validated and patented Digital Biomarkers, we aim at measuring – with unprecedented sensitivity – changes in motor and cognitive functions in patients with neurological disorders. These novel biomarkers will establish a new standard for both pharmacological research and clinical practice.	Digital Biomarkers Development	Light Search	Basel (Switzerland)	2012	51 - 200	$4.20M	Seed, August 31, 2022	Oct 14, 2024
ThinkSense	The company excels in remote monitoring and digital biomarker identification, supporting clinical trials and advancing digital health technologies.	Developer of digital biomarker sensors based in Washington, Virginia. The company offers raw sensor data, participant activity tracking, anonymization of data, data collection, clinical trials, digital biomarker datasets, and more.	Digital Biomarkers Development	Light Search	Washington (United States)	2022	1 - 10		NA	Oct 14, 2024
Cogniant	Cogniant effectively employs remote monitoring technologies to advance clinical trials and identify digital biomarkers, contributing to the development of innovative health solutions.	Cogniant is an AI-assisted digital health platform for monitoring chronic and mental health conditions. Cogniant collects thousands of data points of clients’ daily routines via devices and smartphone sensors. This allows for behavior monitoring whilst educating clients towards better treatment outcomes and connecting them to caregivers and providers for chronic and co-morbid mental health conditions.	Digital Biomarkers Development	Light Search	Singapore (Singapore)	2015	1 - 10	$120.00K	Pre-Seed, $120.00K, January 10, 2021	Oct 14, 2024
DigiBio	DigiBiomarkers effectively utilizes remote monitoring technologies to enhance clinical trials and identify digital biomarkers for health tracking.	DigiBiomarkers provides a platform for capturing frequent and objective patient-level data. The company focuses on enabling healthcare providers to collect and analyze biometric data through digital means. This data helps in monitoring patient health and improving clinical outcomes. DigiBiomarkers leverages technology to facilitate better decision-making in healthcare settings.	Digital Biomarkers Development	Light Search	Carmel-by-the-Sea (United States)	2016	1 - 10		NA	Oct 14, 2024
Biofourmis	Biofourmis excels in remote patient monitoring, advancing clinical trials, and identifying digital biomarkers, making it a strong fit for the specified requirements.	Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.	Digital Biomarkers Development	With Momentum Light Search	Boston (United States)	2015	201 - 500	$463.57M	Acquired by CopilotIQ, October 2024	Oct 14, 2024

Use "Get more companies" to continue searching, or run a “Deep Dive” for a comprehensive mapping